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Background/Aims
Dysfunction of the gastrointestinal tract occurs in about 76% of patients who are diabetic for more than 10 years. Although 
diabetes-related dysfunctions of the stomach such as gastroparesis have been extensively studied over the recent years, studies 
about the mechanism underlying colonic symptoms in long-term diabetes models are rare. Therefore, the goal of our study 
was to clarify the nature of colonic dysfunction in a long-term diabetic rat model. 
Methods
The characteristics of colonic smooth muscle were investigated in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, an animal 
model of type 2 diabetes. These results were compared to those obtained from Long-Evans Tokushima Otsuka (LETO) control 
rats. 
Results
Spontaneous contractility of the proximal colon was significantly decreased in the diabetic rats compared to the controls, while 
the spontaneous contractility of the distal colon was not. The number of interstitial cells of Cajal networks in the proximal co-
lon was greatly decreased in diabetic rats compared to the controls. Contractility of the proximal colon in response to carba-
chol, an acetylcholine receptor agonist, was significantly weaker in the diabetic rats. In addition, the degree of relaxation in 
response to nitric oxide in the proximal colon of diabetic rats also appeared to be attenuated. 
Conclusions
The results from our study suggest that the decrease of interstitial cells of Cajal network, cholinergic receptors, and neuronal 
nitric oxide synthase in the proximal colon plays important roles in diabetes-related dysfunction of colon.
(J Neurogastroenterol Motil 2011;17:372-380)
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Introduction
Diabetes and its long-term complications, including car-
diovascular, renal, neurologic and ophthalmic diseases, represent 
a major cause of morbidity and mortality throughout the world.
1 
It has been reported that 76% of outpatients with diabetes have 
one or more gastrointestinal (GI) symptoms such as nausea, vom-
iting, early satiety, abdominal pain, constipation, diarrhea and fe-
cal incontinence.
2-8 The prevalence of diabetes-related GI symp-
toms may negatively impact the patient’s quality of life.
9
There have been many reports about upper GI symptoms, es-
pecially gastroparesis, in diabetic patients.
6,8,10-13 However, few 
studies about the mechanism underlying colonic symptoms in 
long-term diabetes models have been conducted and produced 
conflicting results.
14,15 In many reports, these GI symptoms are 
thought to be results of abnormal GI motility that, in turn, may 
be a manifestation of diabetic autonomic neuropathy involving 
the GI tract.
3,5,6,8 Increasing evidence, however, indicates that GI 
symptoms in diabetic patients are multifactorial.
16,17 Hyperglyce-
mia can impair gastric and small intestinal motility
18,19 and auto-
nomic neuropathy cannot be considered as the only reason for GI 
motility disorders.
20
Interstitial cells of Cajal (ICC) have been identified as a pace-
maker and mediators of neurotransmission in the GI tract, and so 
play a central role in GI motility.
21 The involvement of ICC in di-
abetic gastroenteropathies was recognized relatively recently.
13,21 
Since then, several studies have reported the depletion of ICC 
networks in both diabetic patients and various diabetic animal 
models.
11,14
In the present study, we analyzed Otsuka Long-Evans 
Tokushima Fatty (OLETF) rats older than 1 year as a long-term 
type 2 diabetes mellitus (DM) model. The clinical and patho-
logical features of diabetes in OLETF rats closely resemble those 
of humans with type 2 DM.
22 We evaluated colonic motility, the 
cholinergic/nitrergic response, and ICC networks in OLETF 
rats to clarify the pathogenesis of the lower GI symptoms asso-
ciated with type 2 DM.
Materials and Methods
Experimental Animals
Six male OLETF and 6 male Long-Evans Tokushima 
Otsuka (LETO) rats older than 60 weeks were used. All animals 
were allowed free access to water and food, and were maintained 
in a controlled environment with alternating 12 hour light/dark 
cycles. All animal procedures were approved by the Institutional 
Guideline Committee for Animal Experiments, Keimyung uni-
versity school of medicine.
Tissue Preparations
Tissue specimens were collected from the proximal (about 1 
cm from the cecum) and distal (about 1 cm from the rec-
tosigmoid junction) colon. The mucosal layer was peeled off and 
transferred to a dissecting dish containing oxygenated (95% O2 
and 5% CO2) Krebs solution with the following composition: 118 
mM NaCl, 4.7 mM KCl, 1.2 mM KH2PO4, 25 mM NaHCO3, 
2.5 mM CaCl, and 11 mM glucose. Colonic circular muscle 
strips (2 × 10 mm) were prepared.
Functional Studies
One side of the colon strip was pinned to the floor of the re-
cording chamber and the opposite side was connected to an iso-
metric force transducer (Grass Technology, West Warwick, RI, 
USA). The strips were allowed to equilibrate for 60 minutes un-
der an initial tension of 0.5 g. During this period, the bath sol-
ution was changed at every 10 minutes with aerated Krebs sol-
ution (95% O2 and 5% CO2). The bath temperature was main-
tained at 37 ± 0.5
oC. Carbachol (1 nM-1 μM; Sigma- Aldrich, 
St. Louis, MO, USA), a cholinergic agonist, was used to eval-
uate the cholinergic system in the proximal colon. L-NG- nitro-
arginine methyl ester (L-NAME, 100 μM; Sigma-Aldrich, St. 
Louis, MO, USA) was used to evaluate the effect of nitric oxide 
on colonic motility. Electrical field stimulation (EFS; 1-10 Hz, 
120 V, 0.5 ms for 30 seconds) was applied between 2 platinum 
plates using a Grass S48 stimulator (Grass Technology) to in-
duce a neuronal response. Tetrodotoxin (TTX, 1 μM; Tocris 
Bioscience, Avonmouth, Bristol, UK) was used to confirm that 
the EFS-induced responses were neuronal. At the beginning of 
each EFS experiment, the strips were pretreated with atropine (1 
μM; Sigma-Aldrich).
Fluorescent Immunohistochemistry
Colonic tissues were fixed in 4% paraformaldehyde and 
washed for 5 minutes with phosphate-buffered saline (PBS, pH 
7.4) with a 3% dehydroxide solution. Sections were preincubated 
with blocking solution (Invitrogen, Carlsbad, CA, USA) for 30 
minutes before being incubated with the following antibodies at 
room temperature: anti-ICC (c-Kit; Santa Cruz Biotechnology, Sun Joo Kim, et al
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Figure 1. Spontaneous contractility of the proximal colon in control (A)
and diabetes mellitus (B) rats. The degree of contractility was expressed
as the area under the curve (AUC) (C). Values are expressed as the 
means ± SEM (n = 6). *P ＜ 0.05 compared to the control. DM, 
diabetes mellitus.
CA, USA), anti-M2 (Abcam, Cambridge, UK), anti-M3 (Santa 
Cruz Biotechnology), and anti-nNOS (Abcam). After the sec-
tions were incubated for 1.5 hours with the primary antibodies, 
they were washed with PBS before being incubated with: an 
Alexa Fluor 488 goat anti-rabbit (Invitrogen) or Alexa Fluor 546 
goat anti-mouse (Invitrogen) secondary antibodies for 1.5 hours 
at room temperature. After being washed with PBS, the speci-
mens were counter-stained with 4’,6-diamidino-2-phenylindole 
(DAPI) and mounted. The immuno-stained tissues were ob-
served by confocal laser scanning microscope (LSM 5 
EXCITER; Carl Zeiss, Jena, Germany), using a C-Apochromat 
objective lens (×40). The confocal images shown are digital 
composites of Z-series scans of 30 optical sections (1.0 μm thick) 
through a depth of full or partial thickness of the musculature. 
Image analysis was completed with LSM 5 EXCITER software 
(Carl Zeiss).
Statistical Methods
The results are expressed as the mean ± SEM. The SPSS 
statistical package (version 14.0; SPSS Inc, Chicago, IL, USA) 
was used for statistical analyses. The area under the curve (AUC) 
was calculated using LabChart 7 software (AD Instrument, 
Colorado Springs, CO, USA). Differences between the 2 groups 
were analyzed using Student’s t test. A P-value less than 0.05 was 
considered to be statistically significant.
Results
Spontaneous Contractile Activity
Spontaneous contractility of the proximal and distal colon 
was examined. Spontaneous contractility of the proximal colon 
significantly decreased in diabetic rats compared to the control 
rats, while that of the distal colon was not (Fig. 1A and 1B). The 
AUC of spontaneous contractility significantly decreased for the 
diabetic rats compared to the controls (Fig. 1C). Therefore, we 
performed subsequent experiments to study the proximal colon.
Identification of the Interstitial Cells of Cajal 
Network
Identification of ICC was made with antibodies against the 
receptor tyrosine kinase, Kit.
21 We observed Kit-positive cells in 
the proximal colon. The ICC network of the proximal colon was 
greatly decreased in the diabetic rats compared to the control rats 
(Fig. 2).
Response to Cholinergic Agonist
Muscle strips from control rats responded to carbachol with a 
progressive increase of phasic contractile activity in a dose-de-
pendent manner. The AUC was significantly decreased for dia-
betic rats compared to the control rats (Fig. 3).Colonic Contractility in Diabetic Rat
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Figure 2. Network of interstitial cells of 
Cajal in control (A) and diabetes mellitus 
(B) rats. Immunofluorescence corres-
ponding to for c-Kit (green) was pre-
pared in the proximal colon.
Figure 3. Effects of carbachol on the contractility of the proximal colon
in control and diabetes mellitus rats. Values are expressed as the means 
± SEM (n = 6). *P ＜ 0.05 compared to the control value at the same
concentration of carbachol. AUC, area under the curve.
Expression of Muscarinic Receptors
M2 and M3 muscarinic receptors preferentially expressed in 
GI smooth muscles
23,24 were observed in the proximal colon with 
immunofluorescence. Expressions of receptors relative to the 
number of nuclei decreased in the diabetic rats compared to the 
control rats (Fig. 4A and 4B). Co-localizations presented as ex-
pression level decreased in the diabetic rats compared to the con-
trol rats (Fig. 4C and 4D).
Response to Electrical Field Stimulation
EFS (1, 2, 5 and 10 Hz; 120 V; 0.5 ms) was applied for 30 
seconds. In the proximal colon, on-relaxation was noted during 
EFS. As the EFS frequency increased, the AUC of on-relaxation 
decreased in the control rats (Fig. 5A and 5C), whereas this re-
sponse was attenuated in the diabetic rats (Fig. 5B and 5C). To 
further investigate whether the appearance of on-relaxation dur-
ing EFS resulted from nitrergic neurotransmission to the smooth 
muscles, L-NAME was administered for 10 minutes before re-
cording the EFS-induced responses. L-NAME, a non-selective 
nitric oxide synthase (NOS) inhibitor, prevented the appearance 
of on-relaxation during EFS in the both the control and diabetic 
rats (Fig. 5A-5C). EFS caused on-relaxation followed by 
off-contraction; the amplitude of off-contraction increased in the 
control rats (Fig. 5A and 5D) whereas this response was attenu-
ated in the diabetic rats (Fig. 5B and 5D). L-NAME also pre-
vented the appearance of off-contraction after EFS in the both 
the control and diabetic rats (Fig. 5A, 5B and 5D).
Expression of Neuronal Nitric Oxide Synthase
Non-adrenergic, non-cholinergic relaxation is primarily me-
diated by nitric oxide in the colon,
25 and endogenous neuronal ni-
tric oxide synthase (nNOS) plays an important role in regulating 
intestinal motility.
26 Expression of nNOS relative to the number 
of nuclei decreased in the diabetic rats compared to the controls 
(Fig. 6A and 6B). Co-localizations presented as expression level 
were decreased in the diabetic rats compared to the control rats 
(Fig. 6C).
Discussion
This observational animal study showed that decreases of the 
ICC network, cholinergic receptors and nNOS expression in the 
proximal colon play important roles in diabetes-related colonic 
dysfunction.Sun Joo Kim, et al
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Figure 4. Expression of M2 and M3 muscarinic receptors in control (A) and diabetes mellitus (DM) (B) rats. Blue: nuclei, Green: M2 receptors, Red:
M3 receptors (representative data from n = 6). Co-localization of M2 and nuclei in the control and DM rats (C). Co-localization of M3 and nuclei in
control and DM rats (D). Values are expressed as the means ± SEM (n = 6).
A previous study reported higher rates of GI symptoms 
among 149 patients with type 2 DM who were referred to a uni-
versity clinic compared to community controls. In this study, the 
duration of diabetes was the only factor independently associated 
with GI symptoms.
7 Therefore, our experiments were performed 
on male OLETF and LETO rats older than at least 60 weeks as 
an animal model of long-term diabetes. The clinico-pathological 
characteristics of OLETF rats resemble those of humans with 
type 2 DM including late onset of hyperglycemia, a chronic dis-
ease course and resultant end stage.
22
In the present study, we initially examined colonic motility of 
both the proximal and distal colon. However, contractility of the 
distal colon was not different between the 2 groups. Therefore, 
we performed subsequent experiments to evaluate the proximal 
colon. The degree of contractility was estimated with several in-
dicators such as the amplitude, frequency and AUC. Although 
the frequency of spontaneous contraction seemed to be higher in 
the diabetic rats and the amplitude of the contraction waves 
seemed to be larger in control group, these differences were not 
statistically significant. Therefore, we used the AUC as an in-
dicator of contractility; by doing this, a significant difference be-
tween the 2 groups was observed.Colonic Contractility in Diabetic Rat
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Figure 5. Response to electric field stimulation (EFS) in the proximal colon. (A) EFS (10 Hz) induced normal patterns of on-relaxation and 
off-contraction response in control rats. These responses disappeared after treatment with L-NG-nitroarginine methyl ester (L-NAME). (B) In 
diabetes mellitus (DM) rat, the degrees of on-relaxation and off-contraction were less than those observed in the control. Both responses also 
disappeared after treatment with L-NAME. (C) Response of on-relaxations of the proximal colon in the control was more dependent on the EFS 
frequency than that of DM rats. (D) Response of off-contractions of the proximal colon in the control and DM rats. Values are expressed as the means
± SEM (n = 6). *P ＜ 0.05 compared to the control value at the stimulation of same frequency. **P ＜ 0.001 compared to the control value at the 
stimulation of same frequency. AUC, area under the curve.
In the proximal colon of the diabetic rats, the ICC network 
was greatly decreased compared to that of the controls. Addition-
ally, expression of cholinergic receptors and nNOS was de-
creased in the diabetes rats. However, we could not estimate the 
change in the number of ICC. To estimate the number of ICC or 
to observe the whole network of ICCs, it is necessary to dissect 
the specimen horizontally through the myenteric plexus. However, 
we could not perform this procedure because the specimen was 
not thick enough. Instead, we observed the morphology and de-
gree of c-Kit expression with confocal microscopy.
ICC are mesenchymal cells that are found throughout the 
muscular coat of the GI tract. These cells perform functions crit-
ical for normal GI motility including the generation and prop-
agation of electrical slow waves and mediation of bidirectional 
communication between the autonomic nervous system and 
smooth muscle cells.
27 It is also well established that ICC serve as 
pacemaker cells responsible for promoting spontaneous con-
tractions of the smooth muscle coats.
28,29 ICC deficiencies and ul-
trastructural changes in GI muscle have been reported in diabetic 
animal models.
13,30 A similar deficiency of ICC has also been de-
scribed in a case report of an insulin-dependent DM patient
31 
and a study of 7 patients with DM.
32 It remains unclear whether 
this ICC deficiency in colonic smooth muscle is related to the 
lower rate of GI symptoms associated with type 2 DM. Since 
ICC are GI pacemaker cells, it can be postulated that impairment 
of the ICC network can variably affect to the contractile pattern 
of smooth muscles (eg, dysrrhythmia, absence or decrease). 
Although we could observe only decreased contractility, further Sun Joo Kim, et al
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Figure 6. Expression of neuronal nitric 
oxide synthase (nNOS) in the control 
(A) and diabetes mellitus (DM) (B) rats.
Blue: nuclei, Green: nNOS (represent-
ative data from n = 6). Co-localization of 
nNOS and nuclei in the control and DM
rats (C). Values are expressed as the 
means ± SEM (n = 6).
investigation may induce other abnormalities.
ICC within the GI tract express a number of neurotrans-
mitter, their receptors and modulators including acetylcholine re-
ceptors (M2 and M3), tachykinin receptors (NK1 and NK3), 
vasoactive intestinal peptide-1 and nNOS.
33-38 I n  G I  s m o o th 
muscles, M2 and M3 muscarinic receptors are preferentially ex-
pressed with a preponderance of the former subtype.
23,24 The 
contractile response to externally administered agonists or chol-
inergic nerve stimulation has been shown to be promoted by ei-
ther M2 or M3 receptors.
39,40 Little is known about the alteration 
of these muscarinic receptors in the long-term diabetic rat model. 
Endogenous nNOS plays an important role in non-adrenergic, 
non-cholinergic intestinal relaxation.
25,26 Neuronal NOS defi-
ciencies in the GI muscle layer and/or delayed gastric emptying 
have been observed in both diabetic animal models
41-44 and pa-
tients with DM.
31
Our study had several limitations. First, the number of ani-
mals we studied was small because it was difficult to maintain old 
diabetic rats as well preserved condition. Second, experiments 
were not performed to examine the distal colon only because no 
significant difference in simple contractility was observed be-
tween the 2 groups. Third, as mentioned above, we could not es-
timate changes in number of ICC. Despite these limitations, the 
results from this study still indicated the involvement of several 
mechanisms in diabetic colonic dysmotility in our long-term dia-
betic rat model which resemble humans with type 2 DM.Colonic Contractility in Diabetic Rat
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In conclusion, we showed that spontaneous contractility, 
cholinergic responses and nitrergic responses in the proximal co-
lon were attenuated in a long-term diabetic rat model. We specu-
lated that the loss of the ICC network might have decreased 
spontaneous contractility. We also hypothesized that decreased 
numbers of M2/M3 receptors and nNOS expression might have 
blunted the cholinergic and nitrergic responses, respectively. 
These results suggest that decreases of the ICC network, the 
number of cholinergic receptors and nNOS expression in the 
proximal colon affect DM-related symptoms of the lower GI in 
long-term diabetic rats. Further investigation is required to iden-
tify the precise mechanism underlying lower GI symptoms in pa-
tients with diabetes.
References
1. Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the 
U.S.: 1990-1998. Diabetes Care 2000;23:1278-1283.
2. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz 
M. Prevalence of gastrointestinal symptoms associated with diabetes 
mellitus: a population-based survey of 15,000 adults. Arch Intern 
Med 2001;161:1989-1996.
3. Enck P, Rathmann W, Spiekermann M, et al. Prevalence of gastro-
intestinal symptoms in diabetic patients and non-diabetic subjects. Z 
Gastroenterol 1994;32:637-641.
4. Farup CE, Leidy NK, Murray M, Williams GR, Helbers L, 
Quigley EM. Effect of domperidone on the health-related quality of 
life of patients with symptoms of diabetic gastroparesis. Diabetes 
Care 1998;21:1699-1706.
5. Feldman M, Schiller LR. Disorders of gastrointestinal motility asso-
ciated with diabetes mellitus. Ann Intern Med 1983;98:378-384.
6. Horowitz M, Fraser R. Disordered gastric motor function in dia-
betes mellitus. Diabetologia 1994;37:543-551.
7. Ko GT, Chan WB, Chan JC, Tsang LW, Cockram CS. Gastroin-
testinal symptoms in Chinese patients with Type 2 diabetes mellitus. 
Diabet Med 1999;16:670-674.
8. Koch KL. Diabetic gastropathy: gastric neuromuscular dysfunction 
in diabetes mellitus: a review of symptoms, pathophysiology, and 
treatment. Dig Dis Sci 1999;44:1061-1075.
9. Talley N J, Young  L , B ytzer P , et al. I m pact o f c hronic  g as tro-
intestinal symptoms in diabetes mellitus on health-related quality of 
life. Am J Gastroenterol 2001;96:71-76.
10. Horváth VJ, Vittal H, Lörincz A, et al. Reduced stem cell factor links 
smooth myopathy and loss of interstitial cells of Cajal in murine dia-
betic gastroparesis. Gastroenterology 2006;130:759-770.
11. Iwasaki H, Kajimura M, Osawa S, et al. A deficiency of gastric inter-
stitial cells of Cajal accompanied by decreased expression of neuronal 
nitric oxide synthase and substance P in patients with type 2 diabetes 
mellitus. J Gastroenterol 2006;41:1076-1087.
12. James AN, Ryan JP, Crowell MD, Parkman HP. Regional gastric 
contractility alterations in a diabetic gastroparesis mouse model: ef-
fects of cholinergic and serotoninergic stimulation. Am J Physiol 
Gastrointest Liver Physiol 2004;287:G612-G619.
1 3 . O r d ö g  T ,  T a k a y am a  I ,  C h e u ng  W K ,  W ar d  S M ,  Sa n d e r s  K M . 
Remodeling of networks of interstitial cells of Cajal in a murine mod-
el of diabetic gastroparesis. Diabetes 2000;49:1731-1739.
14. Forrest A, Huizinga JD, Wang XY, Liu LW, Parsons M. Increase 
in stretch-induced rhythmic motor activity in the diabetic rat colon is 
associated with loss of ICC of the submuscular plexus. Am J Physiol 
Gastrointest Liver Physiol 2008;294:G315-G326.
15. Imaeda K, Takano H, Koshita M, Yamamoto Y, Joh T, Suzuki H. 
Electrical properties of colonic smooth muscle in spontaneously 
non-insulin-dependent diabetic rats. J Smooth Muscle Res 1998; 
34:1-11.
16. Clouse RE, Lustman PJ. Gastrointestinal symptoms in diabetic pa-
tients: lack of association with neuropathy. Am J Gastroenterol 
1989;84:868-872.
17. Quan C, Talley NJ, Jones MP, Spies J, Horowitz M. Gain and loss 
of gastrointestinal symptoms in diabetes mellitus: associations with 
psychiatric disease, glycemic control, and autonomic neuropathy over 
2 years of follow-up. Am J Gastroenterol 2008;103:2023-2030.
18. Abrahamsson H. Gastrointestinal motility disorders in patients with 
diabetes mellitus. J Intern Med 1995;237:403-409.
19. De Boer SY, Masclee AA, Lamers CB. Effect of hyperglycemia on 
gastrointestinal and gallbladder motility. Scand J Gastroenterol 1992; 
27(suppl 194):13-18.
20. Pozzi M, Rivolta M, Gelosa M, et al. Upper gastrointestinal involve-
ment in diabetes mellitus: study of esophagogastric function. Acta 
Diabetol Lat 1988;25:333-341.
21. Sanders KM, Koh SD, Ward SM. Interstitial cells of Cajal as pace-
makers in the gastrointestinal tract. Annu Rev Physiol 2006;68:307- 
343.
22. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. 
Spontaneous long-term hyperglycemic rat with diabetic complica-
tions. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. 
Diabetes 1992;41:1422-1428.
23. Eglen RM, Peelle B, Pulido-Rios MT, Leung E. Functional inter-
actions between muscarinic M2 receptors and 5-hydroxytryptamine 
(5-HT)4 receptors and beta 3-adrenoceptors in isolated oesophageal 
muscularis mucosae of the rat. Br J Pharmacol 1996;119:595-601.
24. Ehlert FJ, Ostrom RS, Sawyer GW. Subtypes of the muscarinic re-
ceptor in smooth muscle. Life Sci 1997;61:1729-1740.
25. Takahashi T, Owyang C. Regional differences in the nitrergic in-
nervation between the proximal and the distal colon in rats. Gastroen-
terology 1998;115:1504-1512.
26. Mizuta Y, Takahashi T, Owyang C. Nitrergic regulation of colonic 
transit in rats. Am J Physiol 1999;277(2 Pt 1):G275-G279.
27. Ordög T. Interstitial cells of Cajal in diabetic gastroenteropathy. 
Neurogastroenterol Motil 2008;20:8-18.
28. Huizinga JD. Gastrointestinal peristalsis: joint action of enteric 
nerves, smooth muscle, and interstitial cells of Cajal. Microsc Res 
Tech 1999;47:239-247.
29. Thuneberg L. Interstitial cells of Cajal: intestinal pacemaker cells? 
Adv Anat Embryol Cell Biol 1982;71:1-130.
30. Long QL, Fang DC, Shi HT, Luo YH. Gastro-electric dysrhythm 
and lack of gastric interstitial cells of Cajal. World J Gastroenterol 
2004;10:1227-1230.
31. He CL, Soffer EE, Ferris CD, Walsh RM, Szurszewski JH, Sun Joo Kim, et al
380 Journal of Neurogastroenterology and Motility 
Farrugia G. Loss of interstitial cells of Cajal and inhibitory in-
nervation in insulin-dependent diabetes. Gastroenterology 2001;121: 
427-434.
32. Nakahara M, Isozaki K, Hirota S, et al. Deficiency of KIT-positive 
cells in the colon of patients with diabetes mellitus. J Gastroenterol 
Hepatol 2002;17:666-670.
33. Epperson A, Hatton WJ, Callaghan B, et al. Molecular markers ex-
pressed in cultured and freshly isolated interstitial cells of Cajal. Am J 
Physiol Cell Physiol 2000;279:C529-C539.
34. Horiguchi K, Sanders KM, Ward SM. Enteric motor neurons form 
synaptic-like junctions with interstitial cells of Cajal in the canine gas-
tric antrum. Cell Tissue Res 2003;311:299-313.
35. Iino S, Ward SM, Sanders KM. Interstitial cells of Cajal are func-
tionally innervated by excitatory motor neurones in the murine 
intestine. J Physiol 2004;556(Pt 2):521-530.
36. Smith VC, Sagot MA, Wong H, Buchan AM. Cellular expression of 
the neurokinin 1 receptor in the human antrum. J Auton Nerv Syst 
2000;79:165-172.
37. Ward SM, Beckett EA, Wang X, et al. Interstitial cells of Cajal me-
diate cholinergic neurotransmission from enteric motor neurons. J 
Neurosci 2000;20:1393-1403.
38. Ward SM, Morris G, Reese L, Wang XY, Sanders KM. Interstitial 
cells of Cajal mediate enteric inhibitory neurotransmission in the low-
er esophageal and pyloric sphincters. Gastroenterology 1998;115: 
314-329.
39. Unno T, Matsuyama H, Izumi Y, Yamada M, Wess J, Komori S. 
Roles of M2 and M3 muscarinic receptors in cholinergic nerve-in-
duced contractions in mouse ileum studied with receptor knockout 
mice. Br J Pharmacol 2006;149:1022-1030.
40. Unno T, Matsuyama H, Sakamoto T, et al. M(2) and M(3) muscar-
inic receptor-mediated contractions in longitudinal smooth muscle of 
the ileum studied with receptor knockout mice. Br J Pharmacol 
2005;146:98-108.
41. Cellek S, Foxwell NA, Moncada S. Two phases of nitrergic neuro-
pathy in streptozotocin-induced diabetic rats. Diabetes 2003;52: 
2353-2362.
42. Takahashi T, Nakamura K, Itoh H, Sima AA, Owyang C. Impaired 
expression of nitric oxide synthase in the gastric myenteric plexus of 
spontaneously diabetic rats. Gastroenterology 1997;113:1535-1544.
43. Watkins CC, Sawa A, Jaffrey S, et al. Insulin restores neuronal nitric 
oxide synthase expression and function that is lost in diabetic 
gastropathy. J Clin Invest 2000;106:373-384.
44. Yu WJ, Juang SW, Chin WT, Chi TC, Chang CJ, Cheng JT. 
Insulin restores neuronal nitric oxide synthase expression in strepto-
zotocin-induced diabetic rats. Life Sci 2000;68:625-634.